These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32016783)

  • 1. Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma.
    Xerfan EMS; Andersen ML; Facina AS; Tufik S; Tomimori J
    World J Pediatr; 2020 Oct; 16(5):537-538. PubMed ID: 32016783
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
    Farshchian M; Potts GA
    Australas J Dermatol; 2021 Nov; 62(4):e580-e581. PubMed ID: 34293182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized hypertrichosis in an infant after treatment with propranolol for infantile hemangioma.
    Mendez-Gallart R; García-Palacios M; Cortizo-Vazquez J; Bautista-Casasnovas A
    Indian J Dermatol Venereol Leprol; 2020; 86(3):311-313. PubMed ID: 32242868
    [No Abstract]   [Full Text] [Related]  

  • 6. Deep coma in a child treated with propranolol for infantile hemangioma.
    Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
    BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How "unsafe" is propranolol when used in the treatment of infantile hemangioma?
    Prashanth GP
    J Am Acad Dermatol; 2012 May; 66(5):854-5; author reply 855-6. PubMed ID: 22507576
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
    Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
    Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral propranolol for infantile haemangioma may be associated with transient gross motor delay.
    Mahon C; Heron G; Perkins D; Drage A; Wargon O
    Br J Dermatol; 2018 Jun; 178(6):1443-1444. PubMed ID: 29330846
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
    Olsen GM; Hansen LM; Stefanko NS; Mathes E; Puttgen KB; Tollefson MM; Lauren C; Mancini AJ; McCuaig CC; Frieden IJ; Adams D; Baselga E; Chamlin S; Gupta D; Frommelt P; Garzon MC; Horii K; Klajn J; Maheshwari M; Newell B; Nguyen HL; Nopper A; Powell J; Siegel DH; Drolet BA
    JAMA Dermatol; 2020 Feb; 156(2):186-190. PubMed ID: 31825455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for infantile haemangiomas and neuroglycopenic seizures.
    Fusilli G; Merico G; Gurrado R; Rosa T; Acquafredda A; Cavallo L
    Acta Paediatr; 2010 Dec; 99(12):1756. PubMed ID: 20726852
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
    Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
    Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In brief: oral propranolol infantile hemangiomas.
    Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of neurodevelopmental abnormalities in children treated with propranolol.
    Labrèze C; Voisard JJ; Delarue A; Moore N
    Br J Dermatol; 2015 Dec; 173(6):1562-4. PubMed ID: 26135132
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol treatment for hemangioma of infancy: risks and recommendations.
    Lawley LP; Siegfried E; Todd JL
    Pediatr Dermatol; 2009; 26(5):610-4. PubMed ID: 19840322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.